We strongly advise you to harness Itamar Medical fundamental analysis to see if markets are presently mispricing the organization. In other words you can makes use of it to find out if Itamar Medical is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found twenty-eight available reported financial drivers for Itamar Medical which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Itamar Medical fundamentals including its Profit Margin, Current Valuation, Price to Sales, as well as the relationship between Operating Margin and Shares Outstanding . Use Itamar Medical to protect against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of Itamar Medical to be traded at S131.97 in 30 days
Itamar Medical Company Summary
Itamar Medical competes with Mazor Robotics, and Elbit Medical. Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the diagnosis of cardiological conditions and sleep breathing disorders in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and internationally. Itamar Medical Ltd. was founded in 1997 and is based in Caesarea, Israel. Itamar Medical operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.
Itamar Medical Ltd is currently regarded as number one stock in z score category among related companies. It is currently regarded as number one stock in shares outstanding category among related companies creating about 6,720,093 of Shares Outstanding per Z Score.
Itamar Medical Market Fundamentals
Itamar Medical Financial Distress Probability
Chance of Financial Distress
Itamar Medical Ltd has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info